Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients. Nischwitz S, Faber H, Sämann PG, Domingues HS, Krishnamoorthy G, Knop M, Müller-Sarnowski F, Yassouridis A, Weber F Acta Neurol Scand. 2014 Jan 25. PMID: 24571587. Abstract CommentRecommendBookmarkWatch